- Patient/Guest
- Phlebotomist
- Updates
| ADA Fluid Test | - |
|---|
|
Measure ADA in fluid |
||
 |
Synonym | See updates |
 |
Test Code | CDBIOPR0002 |
 |
Test Type | Biochemistry |
 |
Pre-Test Condition | See updates |
 |
Report Availability | 2 D(s) |
 |
# Test(s) | 1 |
| Test details | Sample Report |
|---|---|
| ADA Fluid Test |
|
|
Synonym | See updates | |
|
Test Code | CDBIOPR0002 | |
 |
Test Category | Tuberculosis | |
|
Pre-Test Condition | See updates | |
 |
Medical History | See updates | |
|
Report Availability | 2 D(s) | |
 |
Specimen/Sample | Body fluid; 5 mL; St Cont | |
 |
Stability @21-26 deg. C | 6 Hr(s) | |
 |
Stability @ 2-8 deg. C | 24 Hr(s) | |
 |
Stability @ Frozen | NA | |
|
# Test(s) | 1 | |
 |
Processing Method | Spectrophotometry | |
| **Adenosine Deaminase ADA Fluid****FDA Status**: Standard laboratory procedure under CLIA; no specific FDA approval required.**Other Names**: ADA Fluid Test, Fluid Adenosine Deaminase.**Historical Breakthrough**: Developed in the 1980s to diagnose tuberculosis, advancing infectious disease diagnostics.**Key Purpose and Impact**: Measures ADA levels in body fluids to diagnose tuberculous effusions (e.g., pleural, peritoneal).**Preparation and Patient History**: Fluid sample; report fever, weight loss, or tuberculosis exposure.**Consent Requirement**: Varies based on fluid collection method.**Clinical Value**: Sensitivity ~90%; specificity ~95%; detects TB in ~80% of cases; guides therapy.**References Cited**: Testing.com Infectious Disease Tests 2023; Labcorp ADA Test 2025; UpToDate Tuberculosis 2025 |